POPULAR THYROID DRUG LINKED TO BONE LOSS
Johns Hopkins research reveals levothyroxine, taken by 23 million Americans, may accelerate bone loss, raising osteoporosis risks, especially in older adults.
The study of 445 participants, aged 73 on average, found users experienced significant bone density loss over six years, even with normal thyroid levels.
Researchers warn it’s often overprescribed, with 90% of users possibly not needing it.
Osteoporosis, affecting 10 million Americans, leads to fractures and early death.
Patients are urged to reassess treatment and monitor thyroid function regularly.
Source: Daily Mail